These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32421796)

  • 1. The GARDpotency Assay for Potency-Associated Subclassification of Chemical Skin Sensitizers-Rationale, Method Development, and Ring Trial Results of Predictive Performance and Reproducibility.
    Gradin R; Johansson A; Forreryd A; Aaltonen E; Jerre A; Larne O; Mattson U; Johansson H
    Toxicol Sci; 2020 Aug; 176(2):423-432. PubMed ID: 32421796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the GARD™skin Assay for Assessment of Chemical Skin Sensitizers: Ring Trial Results of Predictive Performance and Reproducibility.
    Johansson H; Gradin R; Johansson A; Adriaens E; Edwards A; Zuckerstätter V; Jerre A; Burleson F; Gehrke H; Roggen EL
    Toxicol Sci; 2019 Aug; 170(2):374-381. PubMed ID: 31099396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic allergen rapid detection in-house validation--a proof of concept.
    Johansson H; Rydnert F; Kühnl J; Schepky A; Borrebaeck C; Lindstedt M
    Toxicol Sci; 2014 Jun; 139(2):362-70. PubMed ID: 24675087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GARD platform for potency assessment of skin sensitizing chemicals.
    Zeller KS; Forreryd A; Lindberg T; Gradin R; Chawade A; Lindstedt M
    ALTEX; 2017; 34(4):539-559. PubMed ID: 29156079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high throughput gene expression platforms using a genomic biomarker signature for prediction of skin sensitization.
    Forreryd A; Johansson H; Albrekt AS; Lindstedt M
    BMC Genomics; 2014 May; 15(1):379. PubMed ID: 24886304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the GARD assay in a blind Cosmetics Europe study.
    Johansson H; Gradin R; Forreryd A; Agemark M; Zeller K; Johansson A; Larne O; van Vliet E; Borrebaeck C; Lindstedt M
    ALTEX; 2017; 34(4):515-523. PubMed ID: 28214915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From genome-wide arrays to tailor-made biomarker readout - Progress towards routine analysis of skin sensitizing chemicals with GARD.
    Forreryd A; Zeller KS; Lindberg T; Johansson H; Lindstedt M
    Toxicol In Vitro; 2016 Dec; 37():178-188. PubMed ID: 27638055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting skin sensitizers with confidence - Using conformal prediction to determine applicability domain of GARD.
    Forreryd A; Norinder U; Lindberg T; Lindstedt M
    Toxicol In Vitro; 2018 Apr; 48():179-187. PubMed ID: 29374571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
    Forreryd A; Johansson H; Albrekt AS; Borrebaeck CA; Lindstedt M
    PLoS One; 2015; 10(3):e0118808. PubMed ID: 25760038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.
    Albrekt AS; Johansson H; Börje A; Borrebaeck C; Lindstedt M
    BMC Pharmacol Toxicol; 2014 Feb; 15():5. PubMed ID: 24517095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.
    Johansson H; Lindstedt M; Albrekt AS; Borrebaeck CA
    BMC Genomics; 2011 Aug; 12():399. PubMed ID: 21824406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GARD assay for assessment of chemical skin sensitizers.
    Johansson H; Albrekt AS; Borrebaeck CA; Lindstedt M
    Toxicol In Vitro; 2013 Apr; 27(3):1163-9. PubMed ID: 23032079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of skin sensitization potency using machine learning approaches.
    Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
    J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International ring trial of the epidermal equivalent sensitizer potency assay: reproducibility and predictive-capacity.
    Teunis MA; Spiekstra SW; Smits M; Adriaens E; Eltze T; Galbiati V; Krul C; Landsiedel R; Pieters R; Reinders J; Roggen E; Corsini E; Gibbs S
    ALTEX; 2014; 31(3):251-68. PubMed ID: 24535238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification.
    Natsch A; Haupt T; Wareing B; Landsiedel R; Kolle SN
    ALTEX; 2020; 37(4):652-664. PubMed ID: 32840629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin.
    Gradin R; Forreryd A; Mattson U; Jerre A; Johansson H
    Sci Rep; 2021 Sep; 11(1):18904. PubMed ID: 34556744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
    Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
    Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an optimized protocol using human peripheral blood monocyte derived dendritic cells for the in vitro detection of sensitizers: Results of a ring study in five laboratories.
    Reuter H; Gerlach S; Spieker J; Ryan C; Bauch C; Mangez C; Winkler P; Landsiedel R; Templier M; Mignot A; Gerberick F; Wenck H; Aeby P; Schepky A
    Toxicol In Vitro; 2015 Aug; 29(5):976-86. PubMed ID: 25868915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro approaches to the identification and characterization of skin sensitizers.
    Basketter D; Maxwell G
    Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic understanding of dendritic cell activation in skin sensitization: additional evidences to support potency classification.
    Galbiati V; Marinovich M; Corsini E
    Toxicol Lett; 2020 Apr; 322():50-57. PubMed ID: 31958493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.